How do I qualify a new peptide supplier?
What risk-based qualification process should a laboratory follow before approving a new peptide supplier, and what evidence should be retained for future audits?
General Answer
The search notes provided are unrelated to peptide sourcing (they define the verb "do"), so the answer below draws on domain knowledge of laboratory supplier qualification rather than those notes. No specific supplier names, prices, or performance claims are asserted.
Use a risk-based, staged qualification process. The depth of scrutiny should scale with the material's criticality (e.g., a peptide used in a validated assay or in vivo study vs. a generic reagent), the supplier's role (API manufacturer, custom synthesis house, vialed lyophilized powder producer, or reseller), and the novelty of the supplier.
- 1. Define requirements and risk tier. Document intended use, required purity/identity specs, quantity, and whether the peptide is research-grade or destined for a regulated application. Assign a risk tier (low/medium/high) that sets the evidence burden.
- 2. Paper qualification. Collect business registration, quality manual or quality policy, site information, and a completed supplier questionnaire covering synthesis capability, purification, characterization methods (HPLC, MS), and handling of custom orders.
- 3. Documentation review. Request a representative certificate of analysis (CoA) and verify it states identity, purity by HPLC, mass confirmation, appearance, and storage. Check that test methods are described and that batch numbers are traceable.
- 4. Sample evaluation. Order a small qualification lot and perform incoming testing (identity, purity, appearance, solubility) against your own specifications. Retain the sample and raw data.
- 5. Audit (tier-dependent). For high-risk suppliers, conduct a desk audit or on-site/virtual audit of the manufacturing site, focusing on documentation control, deviation handling, and change notification.
- 6. Approval and agreement. Record the approval decision, define an approved-supplier status, and establish a quality agreement or purchase terms covering change control, complaint handling, and re-qualification triggers.
- 7. Ongoing monitoring. Set a re-qualification interval and monitor incoming test results, complaints, and any supplier-notified changes.
Evidence to retain for audits: the approved-supplier list entry and risk-tier rationale; the supplier questionnaire and business/quality documents; CoAs for each lot received; your own incoming inspection and test records; audit reports and CAPA records; the approval decision and approver; the quality agreement; and a log of complaints, deviations, and change notifications. Keep records organized by supplier and lot so traceability is straightforward.
For teams that also source through intermediaries or need logistics support, our service catalog includes helping research-peptide customers compare and evaluate Chinese peptide API factories, research-peptide raw-material factories, lyophilized-powder vial factories, and international logistics providers (items 8, 9, 11, 12), plus business, legal, customs-clearance, and door-to-door logistics consulting (items 33–36). These are sourcing and logistics aids; the qualification evidence and approval decision remain the laboratory's responsibility.
In short: tier the risk, gather documents, test a sample, audit where warranted, approve formally, and keep a complete, traceable record set.
These answers are general industry information, not regulatory, medical or legal advice. Regulatory status, import rules and clinical suitability must be verified for the specific product, jurisdiction and intended use.